A novel misoprostol delivery system for induction of labor: clinical utility and patient considerations

Drug Des Devel Ther. 2015 Apr 22:9:2321-7. doi: 10.2147/DDDT.S64227. eCollection 2015.

Abstract

Induction of labor is one of the most commonly performed obstetric procedures and will likely become more common as the reproductive population in developed nations changes. As the proportion of women undergoing induction grows, there is a constant search for more efficacious ways to induce labor while maintaining fetal and maternal safety as well as patient satisfaction. With almost half of induced labors requiring cervical ripening, methods for achieving active labor and vaginal delivery are constantly being investigated. Prostaglandins have been shown to be effective induction agents, and specifically vaginal misoprostol, used off-label, have been widely utilized to initiate cervical ripening and active labor. The challenge is to administer this medication accurately while maintaining the ability to discontinue the medication when needed. The misoprostol vaginal insert initiates cervical ripening utilizing a delivery system that controls medication release and can be rapidly removed. This paper reviews the design, development, and clinical utility of the misoprostol vaginal insert for induction of labor as well as patient considerations related to the delivery system.

Keywords: cervical ripening; induction; misoprostol; vaginal insert.

Publication types

  • Review

MeSH terms

  • Administration, Intravaginal
  • Adult
  • Cervical Ripening
  • Chemistry, Pharmaceutical
  • Clinical Trials, Phase I as Topic
  • Clinical Trials, Phase II as Topic
  • Clinical Trials, Phase III as Topic
  • Drug Delivery Systems
  • Drug Implants
  • Female
  • Humans
  • Labor, Induced / methods*
  • Misoprostol / administration & dosage*
  • Misoprostol / adverse effects
  • Misoprostol / pharmacology*
  • Oxytocics / administration & dosage*
  • Oxytocics / adverse effects
  • Oxytocics / pharmacology*
  • Pregnancy

Substances

  • Drug Implants
  • Oxytocics
  • Misoprostol